Attached files
file | filename |
---|---|
EX-23.2 - EX-23.2 - Translate Bio, Inc. | d523294dex232.htm |
EX-5.1 - EX-5.1 - Translate Bio, Inc. | d523294dex51.htm |
EX-3.5 - EX-3.5 - Translate Bio, Inc. | d523294dex35.htm |
S-1/A - S-1/A AMENDMENT NO. 2 - Translate Bio, Inc. | d523294ds1a.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 2 to the Registration Statement on Form S-1 of Translate Bio, Inc. of our report dated March 30, 2018, except for the effects of the reverse stock split discussed in Note 16 to the consolidated financial statements, as to which the date is June 18, 2018, relating to the financial statements of Translate Bio, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
June 18, 2018